Ether

Ether

SCHEMBL1193753

CCCN.CCOCC

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ether SCHEMBL1092093 0.88
Ether SCHEMBL2582345 0.84
Butylamine SCHEMBL21143656 0.83 DNM1 (0.53)
Ether SCHEMBL11771529 0.81 DNM1 (0.42)
Ether SCHEMBL8910286 0.81 DNM1 (0.67)
Propylamine SCHEMBL28323112 0.81
Ether SCHEMBL23611026 0.79
Ether SCHEMBL7600629 0.79 ALDH1A1 (0.41)
Ether SCHEMBL5738680 0.79 ALDH1A1 (0.41)
Ether SCHEMBL641155 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311026-B Method and collector composition for treating magnetite ore 阿克苏诺贝尔化学品国际有限公司 2020-02-28 CN claimed
US-20190263750-A1 IN VIVO GELLING PHARMACEUTICAL PRE-FORMULATION THERAGENICS CORPORATION 2019-08-29 US claimed
CN-106190450-B A kind of alcohol ether borate type braking fluid 辽宁道博精细化学品生产有限公司 2019-07-16 CN claimed
CN-109311026-A Method and collector composition for treating magnetite ore 阿克苏诺贝尔化学品国际有限公司 2019-02-05 CN claimed
CN-106190451-A A kind of preparation method of alcohol ether borate type braking fluid 辽宁道博精细化学品生产有限公司 2016-12-07 CN claimed
CN-106190450-A A kind of alcohol ether borate type braking fluid 辽宁道博精细化学品生产有限公司 2016-12-07 CN claimed
EP-2846847-A1 BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT Medicus Biosciences LLC (US) 2015-03-18 EP claimed
WO-2013170195-A1 BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT MEDICUS BIOSCIENCES, LLC (US) 2013-11-14 WO claimed
US-20130116341-A1 IN-VIVO GELLING PHARMACEUTICAL PRE-FORMULATION MEDICUS BIOSCIENCES, LLC (US) 2013-05-09 US claimed
WO-2011140519-A2 IN VIVO GELLING PHARMACEUTICAL PRE-FORMULATION MEDICUS BIOSCIENCES, LLC (US) 2011-11-10 WO claimed
US-11864558-B2 Herbicidal compositions containing N-phosphonomethyl glycine and an auxin herbicide MONSANTO TECHNOLOGY LLC (US) 2024-01-09 US disclosed
US-20230218799-A1 BIOCOMPATIBLE HYDROGEL TREATMENTS FOR RETINAL DETACHMENT AQUARIAN CREDIT FUNDING LLC 2023-07-13 US disclosed
EP-2968680-B1 SOLID POLYGLYCOL-BASED BIOCOMPATIBLE PRE-FORMULATION C P MEDICAL CORP (US) 2023-05-03 EP disclosed
US-11596710-B2 Biocompatible hydrogel treatments for retinal detachment AQUARIAN CREDIT FUNDING LLC 2023-03-07 US disclosed
US-20210322785-A1 COMPOSITIONS AND METHODS FOR TREATING WOUNDS THERAGENICS CORPORATION 2021-10-21 US disclosed
US-5928944-A TREATING EUKARYOTIC CELL WITH ADENOVIRUS BEFORE, DURING OR AFTER INCUBATING WITH NUCLEIC ACID; OPTIONAL USE OF CATIONIC AGENTS THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-07-27 US disclosed
WO-1995021259-A1 ADENOVIRAL-MEDIATED METHOD OF CELL TRANSFECTION THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1995-08-10 WO disclosed
US-4678562-A FATTY ALCOHOL SHEREX CHEMICAL COMPANY, INC. (US) 1987-07-07 US disclosed
US-4678561-A NITRILES SHEREX CHEMICAL COMPANY, INC. (US) 1987-07-07 US disclosed
US-4589980-A ADDING A HYDROPHOBIC NONIONIC FATTY ACID OR ESTER; DEASHING; BENEFICIATION SHEREX CHEMICAL COMPANY, INC. (US) 1986-05-20 US disclosed